Precision Medicine Group

Highly Engaged Employees

Precision Medicine Group, founded in 2012, is a life sciences services firm specializing in drug development and commercialization. The company operates through two primary platforms: Precision for Medicine, which delivers clinical research, laboratory, genomics, and data science services, and Precision AQ, which focuses on market access, medical communications, and payer insights. By integrating these technical capabilities, the firm supports biopharmaceutical clients from early-stage development through to commercial launch.

With a workforce of 1,000-5,000 employees, the organization maintains a significant global footprint across North America, Europe, and Asia-Pacific. The company leverages its specialized expertise to provide mission-critical services for complex drug development programs. Meet Precision Medicine Group's team to learn about their leadership and organizational structure, which supports their extensive service portfolio in the competitive life sciences sector.

Precision Medicine Group demonstrates strong market presence with annual revenue of $1.2B. The firm competes with major industry players such as Medpace, Charles River, and Catalent, positioning itself as a key partner in the biopharmaceutical ecosystem. Explore financial highlights for detailed metrics regarding their growth and funding history, including significant private equity and debt financing rounds that have fueled their expansion since inception.